NHS Logo
  • Home
  • About Us
    • NIHR Imperial BRC Team
    • Equality, Diversity and Inclusion (EDI) Strategy
    • NIHR Infrastructures
    • Acknowledgement
    • Research Guidance & Useful Links
    • NIHR Imperial BRC Branding Guidance
  • Research
    • Biomedical Engineering
    • Brain Sciences
    • Cardiovascular
    • Digestive Diseases
    • Digital Health
    • Immunology
    • Infection & Antimicrobial Resistance
    • Metabolic & Endocrinology
    • Molecular Phenotyping
    • Multiple Long-term Conditions (MLTC)
    • Pregnancy & Prematurity
    • Respiratory
    • Social, Genetic & Environmental Determinants of Health (SGE)
    • Surgery & Cancer
  • Facilities/Services
    • Clinical Imaging Facility
    • Clinical Phenotyping Centre
    • Flow Cytometry
    • Genomics Facility
    • Imperial College Healthcare Tissue Bank
    • iCARE
    • Imperial Clinical Trials Unit
    • Imperial Health Knowledge Bank (IHKB)
    • Organoid Facility
    • Patient Experience Research Centre (PERC)
    • The Leonard and Dora Colebrook Laboratory
  • Patient/Public
    • Research We Are Supporting
    • How You Can Get Involved
    • Information for Researchers
    • Public Involvement, Engagement and Participation in Research Summary Strategy
  • Industry/Partners
    • Collaborations
    • Contract
    • Commercialisation
  • Training
    • Non-Medical Opportunities
    • Chain Florey Clinician Scientist Programme
    • Clinical Academic Training Office
    • Other Training Schemes
  • News & Events
    • Upcoming Events
    • Newsletter
  • Contact Us

Prevention Stories

PartnershipPPIEPreventionTherapeutic Breaking the Silence on Baby Loss

PartnershipPPIEPreventionTherapeutic Breaking the Silence on Baby Loss

Published on 5th December 2023
Prevention Reversal of CPI-colitis by targeting IFNγ-producing immune cells provides hope for improved outcomes for cancer patients

Prevention Reversal of CPI-colitis by targeting IFNγ-producing immune cells provides hope for improved outcomes for cancer patients

Published on 1st November 2023
InnovationPrevention NIHR Imperial BRC Organoid Facility takes inventions a step closer to disease modelling and precision medicine

InnovationPrevention NIHR Imperial BRC Organoid Facility takes inventions a step closer to disease modelling and precision medicine

Published on 31st October 2023
Prevention Serious food allergic patients are frequently not being prescribed potentially lifesaving medication

Prevention Serious food allergic patients are frequently not being prescribed potentially lifesaving medication

Published on 17th October 2023
Prevention Young people with ulcerative colitis at risk due to low adherence to prescribed medication

Prevention Young people with ulcerative colitis at risk due to low adherence to prescribed medication

Published on 18th September 2023
Information for Patients and the Public
  • Research We Are Supporting
  • How You Can Get Involved
  • Public Involvement, Engagement and Participation in Research Summary Strategy
Latest News
  • Event Care Minister visits UK Dementia Research Institute at White City
  • Prevention Harnessing Data to Transform Inpatient Diabetes Care
  • Appointment Imperial Professors Elected to Prestigious Academy of Medical Sciences
NIHR Imperial Biomedical Research Centre

The National Institute for Health and Care Research (NIHR) Imperial Biomedical Research Centre (BRC) is part of the NIHR and hosted by Imperial College Healthcare NHS Trust in partnership with Imperial College London


Accessibility
Privacy
Terms & Conditions

The information contained in this website is for general use only. We endeavour to keep the information on the site up to date and correct, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose.

© 2025 - NIHR Imperial Biomedical Research Centre